Lineage, Inc. Common Stock (LINE)vsTPG RE Finance Trust Inc (TRTX)
LINE
Lineage, Inc. Common Stock
$42.63
-1.32%
REAL ESTATE · Cap: $11.14B
TRTX
TPG RE Finance Trust Inc
$8.45
+0.84%
REAL ESTATE · Cap: $657.12M
Smart Verdict
WallStSmart Research — data-driven comparison
Lineage, Inc. Common Stock generates 3835% more annual revenue ($5.36B vs $136.23M). TRTX leads profitability with a 48.1% profit margin vs -2.7%. TRTX earns a higher WallStSmart Score of 68/100 (B-).
LINE
Avoid34
out of 100
Grade: F
TRTX
Strong Buy68
out of 100
Grade: B-
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Reasonable price relative to book value
Reasonable price relative to book value
Keeps 48 of every $100 in revenue as profit
Strong operational efficiency at 50.7%
Earnings expanding 58.3% YoY
Attractively priced relative to earnings
Areas to Watch
0.4% revenue growth
0.0% earnings growth
Operating margin of 3.3%
Elevated debt levels
Smaller company, higher risk/reward
ROE of 6.2% — below average capital efficiency
Weak financial health signals
Distress zone — elevated risk
Comparative Analysis Report
WallStSmart ResearchBull Case : LINE
The strongest argument for LINE centers on Price/Book.
Bull Case : TRTX
The strongest argument for TRTX centers on Price/Book, Profit Margin, Operating Margin. Profitability is solid with margins at 48.1% and operating margin at 50.7%. Revenue growth of 11.9% demonstrates continued momentum.
Bear Case : LINE
The primary concerns for LINE are Revenue Growth, EPS Growth, Operating Margin.
Bear Case : TRTX
The primary concerns for TRTX are Market Cap, Return on Equity, Piotroski F-Score. Debt-to-equity of 3.17 is elevated, increasing financial risk.
Key Dynamics to Monitor
LINE profiles as a turnaround stock while TRTX is a mature play — different risk/reward profiles.
TRTX is growing revenue faster at 11.9% — sustainability is the question.
TRTX generates stronger free cash flow (22M), providing more financial flexibility.
Monitor REIT - INDUSTRIAL industry trends, competitive dynamics, and regulatory changes.
Bottom Line
TRTX scores higher overall (68/100 vs 34/100), backed by strong 48.1% margins and 11.9% revenue growth. Both earn "Strong Buy" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Lineage, Inc. Common Stock
REAL ESTATE · REIT - INDUSTRIAL · USA
Lineage, Inc. (Ticker: LINE) is an innovative biotechnology company specializing in regenerative medicine, with a focus on developing state-of-the-art cell therapies for conditions such as ocular diseases, spinal cord injuries, and various cancers. Leveraging its proprietary technologies and strong strategic partnerships, Lineage aims to revolutionize patient care with pioneering therapeutic solutions. The company’s dedication to advancing its diverse product pipeline and accelerating clinical trials positions it as a compelling investment prospect for institutional investors looking to engage at the cutting edge of healthcare advancements.
Visit Website →TPG RE Finance Trust Inc
REAL ESTATE · REIT - MORTGAGE · USA
TPG RE Finance Trust, Inc., a commercial real estate finance company, originates, acquires and manages commercial mortgage loans and other commercial real estate-related debt instruments in North America. The company is headquartered in New York, New York.
Compare with Other REIT - INDUSTRIAL Stocks
Want to dig deeper into these stocks?